Market Cap 240.01M
Revenue (ttm) 0.00
Net Income (ttm) -44.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 6,464,400
Avg Vol 632,778
Day's Range N/A - N/A
Shares Out 38.59M
Stochastic %K 41%
Beta 1.38
Analysts Strong Sell
Price Target $25.00

Company Profile

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving pare...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 844 0337
Address:
345 Park Avenue South, 3rd Floor, New York, United States
TwongStocks
TwongStocks Dec. 5 at 10:48 PM
$TARA Prospectus for the offering was filed https://www.sec.gov/Archives/edgar/data/1359931/000121390025118744/ea0268632-424b5_protara.htm • Same terms as this morning. 13,043,479 shares at $5.75. If underwriters exercise their options in full, it rises to 15m shares at $5.75. • 51,630,739 shares outstanding after the offering. Rises to 53,587,260 shares if the underwriters’ option is exercised in full. • Net proceeds expected to be $69.7M and $80.2M if underwriters exercise their options in full. • Shares are allocated to the underwriters as follows: JPM 5,217,391 shares, TS Securities 3,260,870 shares, Piper Sandler 2,608,696 shares, LifeSci Capital 1,304,348 shares, and HCW 652,174 shares.
0 · Reply
LeoS_Crmxt27
LeoS_Crmxt27 Dec. 5 at 8:43 PM
$TARA classic micro biotech volatility, only respect it when volume confirms
0 · Reply
mimiwor
mimiwor Dec. 5 at 8:30 PM
$TARA feeling like squeezing move after market is coming..
0 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 7:11 PM
$TARA Thanks for the gifted shares 5.07-5.18 this am.....do not normally shop this early for XMAS but could not ignore the giveaway.....happy to oblige....hope your 5.07-5.18 brings joy for the holidays
0 · Reply
longterminvs
longterminvs Dec. 5 at 6:26 PM
$TARA The Bio5C Discord lit up this morning with frustrated TARA owners surprised at this raise when the previous was $6.25 a year ago and this was $5.75 with more progress and two recent positive announcements. Many feeling it's very odd with a major catalyst. JNap had this opinion:
1 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 5:51 PM
$TARA The institutions accumulate profits on the mistakes of retail investors.....always doing the opposite....retail selling panic today the signal to buy all one can on this opportunity.....the news could not have been any better......relax and buy
0 · Reply
notreload_ai
notreload_ai Dec. 5 at 4:31 PM
$TARA raised $75 million via a stock sale to fund clinical trials, mainly for TARA-002, a treatment for bladder cancer and rare lymphatic issues. The company's stock dropped 20% following the discounted pricing announcement. https://ir.protaratx.com/news-releases/news-release-details/protara-announces-pricing-75-million-public-offering
0 · Reply
pablo4
pablo4 Dec. 5 at 4:18 PM
$TARA even if it dips a bit again before right back forward, TARA is a great buy now, IMO.
0 · Reply
pablo4
pablo4 Dec. 5 at 3:33 PM
$TARA I think a small minority of retail investors in the market today actually research fundamentals of the companies they own. I believe they chase "stories" and learn to follow charts. Charts can be very helpful....stories may play for short spell....but ultimately, the business itself defines the future of real investors. It takes homework to determine the fundamental picture. Reading financials and evaluating pipelines, market potential, competition, results to date for biotechs is essential if you're investment horizon is beyond the next knee-jerk reaction of retailers. TARA is almost the perfect biotech, IMO. It doesn't just have science, but proven science. The bladder cancer results we just saw were stellar. On the CC this week, mgt was giddy and the doctor using the treatment in trials was also giddy. The need is substantial and TARA seems poised to change the landscape for bladder cancer treatment, the 6th most common cancer in the world. I could go on and on....JMO
0 · Reply
Drugtrade
Drugtrade Dec. 5 at 3:11 PM
$TARA near perfect financing execution.. more faith in management now. Cant always get those +500% pump on private placment news.. this isnt that type of investment (bearish tag because i want in sub 5 as if thats gona happen)
0 · Reply
Latest News on TARA
Protara Announces Pricing of $75 Million Public Offering

Dec 4, 2025, 10:03 PM EST - 21 hours ago

Protara Announces Pricing of $75 Million Public Offering


Protara Announces Proposed Public Offering

Dec 4, 2025, 4:15 PM EST - 1 day ago

Protara Announces Proposed Public Offering


Protara Therapeutics: End Of 2025 Proving Eventful Indeed

Dec 4, 2025, 7:30 AM EST - 1 day ago

Protara Therapeutics: End Of 2025 Proving Eventful Indeed


Protara Highlights Recent Updates and Anticipated 2025 Milestones

Jan 13, 2025, 8:00 AM EST - 11 months ago

Protara Highlights Recent Updates and Anticipated 2025 Milestones


Protara Therapeutics: Rising From The Ashes

Dec 14, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics: Rising From The Ashes


Protara Announces Closing of $100 Million Public Offering

Dec 11, 2024, 4:05 PM EST - 1 year ago

Protara Announces Closing of $100 Million Public Offering


Protara Therapeutics: Carving New Roads In Bladder Cancer

Dec 10, 2024, 5:00 PM EST - 1 year ago

Protara Therapeutics: Carving New Roads In Bladder Cancer


Protara Announces Pricing of $100 Million Public Offering

Dec 9, 2024, 11:35 PM EST - 1 year ago

Protara Announces Pricing of $100 Million Public Offering


Protara: A Bombed Out Biotech With A Very Positive Skew

Feb 22, 2024, 8:55 AM EST - 1 year ago

Protara: A Bombed Out Biotech With A Very Positive Skew

CGON


TwongStocks
TwongStocks Dec. 5 at 10:48 PM
$TARA Prospectus for the offering was filed https://www.sec.gov/Archives/edgar/data/1359931/000121390025118744/ea0268632-424b5_protara.htm • Same terms as this morning. 13,043,479 shares at $5.75. If underwriters exercise their options in full, it rises to 15m shares at $5.75. • 51,630,739 shares outstanding after the offering. Rises to 53,587,260 shares if the underwriters’ option is exercised in full. • Net proceeds expected to be $69.7M and $80.2M if underwriters exercise their options in full. • Shares are allocated to the underwriters as follows: JPM 5,217,391 shares, TS Securities 3,260,870 shares, Piper Sandler 2,608,696 shares, LifeSci Capital 1,304,348 shares, and HCW 652,174 shares.
0 · Reply
LeoS_Crmxt27
LeoS_Crmxt27 Dec. 5 at 8:43 PM
$TARA classic micro biotech volatility, only respect it when volume confirms
0 · Reply
mimiwor
mimiwor Dec. 5 at 8:30 PM
$TARA feeling like squeezing move after market is coming..
0 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 7:11 PM
$TARA Thanks for the gifted shares 5.07-5.18 this am.....do not normally shop this early for XMAS but could not ignore the giveaway.....happy to oblige....hope your 5.07-5.18 brings joy for the holidays
0 · Reply
longterminvs
longterminvs Dec. 5 at 6:26 PM
$TARA The Bio5C Discord lit up this morning with frustrated TARA owners surprised at this raise when the previous was $6.25 a year ago and this was $5.75 with more progress and two recent positive announcements. Many feeling it's very odd with a major catalyst. JNap had this opinion:
1 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 5:51 PM
$TARA The institutions accumulate profits on the mistakes of retail investors.....always doing the opposite....retail selling panic today the signal to buy all one can on this opportunity.....the news could not have been any better......relax and buy
0 · Reply
notreload_ai
notreload_ai Dec. 5 at 4:31 PM
$TARA raised $75 million via a stock sale to fund clinical trials, mainly for TARA-002, a treatment for bladder cancer and rare lymphatic issues. The company's stock dropped 20% following the discounted pricing announcement. https://ir.protaratx.com/news-releases/news-release-details/protara-announces-pricing-75-million-public-offering
0 · Reply
pablo4
pablo4 Dec. 5 at 4:18 PM
$TARA even if it dips a bit again before right back forward, TARA is a great buy now, IMO.
0 · Reply
pablo4
pablo4 Dec. 5 at 3:33 PM
$TARA I think a small minority of retail investors in the market today actually research fundamentals of the companies they own. I believe they chase "stories" and learn to follow charts. Charts can be very helpful....stories may play for short spell....but ultimately, the business itself defines the future of real investors. It takes homework to determine the fundamental picture. Reading financials and evaluating pipelines, market potential, competition, results to date for biotechs is essential if you're investment horizon is beyond the next knee-jerk reaction of retailers. TARA is almost the perfect biotech, IMO. It doesn't just have science, but proven science. The bladder cancer results we just saw were stellar. On the CC this week, mgt was giddy and the doctor using the treatment in trials was also giddy. The need is substantial and TARA seems poised to change the landscape for bladder cancer treatment, the 6th most common cancer in the world. I could go on and on....JMO
0 · Reply
Drugtrade
Drugtrade Dec. 5 at 3:11 PM
$TARA near perfect financing execution.. more faith in management now. Cant always get those +500% pump on private placment news.. this isnt that type of investment (bearish tag because i want in sub 5 as if thats gona happen)
0 · Reply
pablo4
pablo4 Dec. 5 at 3:04 PM
$TARA retailers can be stupid....but thanks for selling me some shares below 5.10 today. JMO
0 · Reply
Danyzinho29
Danyzinho29 Dec. 5 at 3:01 PM
$TARA time to jump in?
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 2:57 PM
Losers Today: $SDM $SPWH $TARA $ABLV $QNRX Bookmark this screener: https://stockanalysis.com/markets/losers/?ref=saveontrading
1 · Reply
Eddie5150
Eddie5150 Dec. 5 at 2:55 PM
0 · Reply
LF5
LF5 Dec. 5 at 2:51 PM
$TARA Oversold & overdone. I’m in at 5.25.
0 · Reply
keokeostwiz
keokeostwiz Dec. 5 at 2:35 PM
$TARA Added 10k at firesafe......will now watch institutions fill the void created by retail panic button as usual......the science will not be affected....only the institutional coffers will prosper in a very short time...the future remains very bright for TARA
1 · Reply
thenumbersdontlie
thenumbersdontlie Dec. 5 at 2:20 PM
$TARA I like these micro pharmas better when they are run like underground roulette tables and not actual businesses
0 · Reply
DARKP00L
DARKP00L Dec. 5 at 2:11 PM
$TARA 09:10 on Dec. 05 2025 Protara Therapeutics shares are trading lower after the company announced the pricing of a $75 million public offering of 13,043,479 shares at $5.75 per share. #tradeideas
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 5 at 2:09 PM
$TARA (-20.1% pre) Protara prices $75 million stock offering at $5.75 per share https://ooc.bz/l/86473
0 · Reply
pablo4
pablo4 Dec. 5 at 2:08 PM
$TARA I just added some back I had sold from my trading shares. This premarket activity is from retailers. Institutions will buy up this deal....with the science, you can count on that one to be true. Retailers freak out easily and move on....but TARA is building itself and isn't going anywhere. Thus far, TARA-002 is proving itself to be a very potent compound with potentially many applications to help patients. IMO
1 · Reply
lacyauto
lacyauto Dec. 5 at 2:03 PM
$TARA adding!
0 · Reply
pablo4
pablo4 Dec. 5 at 12:33 PM
$TARA well, I hoped for better pricing....but the science isn't going away.
0 · Reply